2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Endometrial Neoplasms
7
Lymphatic Metastasis
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
3
Breast Neoplasms
3
Thyroid Cancer, Papillary
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Postoperative Complications
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphedema
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Clinical Stage I Gastric Cancer AJCC v8
2
Carcinoma, Transitional Cell
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Urologic Neoplasms
1
Ureteral Neoplasms
1
Thyroid cancer, follicular
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Recurrence
1
Radiation Injuries
1
Prostate Adenocarcinoma
1
Platelet Glycoprotein IV Deficiency
1
Parotid Neoplasms
1
Interventions
Radiotherapy
38
Radiotherapy, Intensity-Modulated
12
Cisplatin
12
Amifostine
11
Paclitaxel
7
Carboplatin
7
Radiosurgery
6
Etoposide
5
Brachytherapy
5
Surgical Procedures, Operative
4
Low-Level Light Therapy
4
Donepezil
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sargramostim
3
Surveys and Questionnaires
3
Radiation
3
Proton Therapy
3
Neuropsychological Tests
3
Mental Status and Dementia Tests
3
Magnetic Resonance Spectroscopy
3
Heavy Ion Radiotherapy
3
Filgrastim
3
Diet Therapy
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Radiotherapy, Conformal
2
Radiation Dose Hypofractionation
2
Patient Reported Outcome Measures
2
Lithium
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radiation Injuries
×
Lymph Node Excision
×
Clear all
NCT04889924
2026-05-19
ADARNAT
Hospital Universitari de Bellvitge
Phase NA
Recruiting
820 enrolled